Azerbaijan, Baku, Oct. 29 /Trend, N. Umid
Iranian experts have achieved the latest technology to produce the Nano micellar form of Curcumin, head of the Nanotechnology Researches Centre of Mahshad University of Medical Science, Mohammad Reza Jafari said, ISNA news agency reported.
Jafari went on to note that Iran will start mass-production of this drug during next three months.
Curcumin mainly found in the plant turmeric, is widely used as a potential protective agent against several chronic diseases including cancer, HIV-infection, neurological, cardio-vascular and skin diseases.
The drug can be used for treating diabetes, Alzheimer, Parkinson and cardio-vascular diseases as well as arthritis, Jafari added.
Iranian experts from the Nanotechnology Researches Centre of Mahshad University of Medical Science also introduced an anti-cancer Nano drug under the name Sinadoxosome to the market, two years ago.
Sinadoxosome contains Nano liposomes that contain doxorubicin anti-cancer medicine. It targets the tumour tissue by using the increase in the permeability mechanism. This boosts the effect of the medicine, but decreases the side effects. The medicine has applications in the treatment of ovarian and breast cancer and leukemia and in the treatment of Kaposi's sarcoma (a type of soft tissue cancer).